'Dual circulation' to boost growth (III)
China DailyWill Song, global senior vice-president and China chairman for Johnson & Johnson. Johnson & Johnson's business has witnessed strong growth in China since the second quarter, leading the global market. For example, our Medical Devices business achieved double-digit growth in both the second and third quarters, further boosting China's share in Johnson & Johnson's global business portfolio. In particular, our medical devices business has witnessed significant double-digit growth in Q2 and Q3, further increasing China's share in the company's global business portfolio. Under the post-pandemic new normal, we believe China will be playing an increasingly strategic role for Johnson & Johnson's global business and truly fulfill our position as the duel engine.